Cargando…

AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease

Over the past three years, significant progress has been made in the development of novel promising drug candidates against COVID-19. However, SARS-CoV-2 mutations resulting in the emergence of new viral strains that can be resistant to the drugs used currently in the clinic necessitate the developm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrianov, Alexander M., Shuldau, Mikita A., Furs, Konstantin V., Yushkevich, Artsemi M., Tuzikov, Alexander V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178971/ https://www.ncbi.nlm.nih.gov/pubmed/37175788 http://dx.doi.org/10.3390/ijms24098083

Ejemplares similares

In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4
por: Andrianov, Alexander M., et al.
Publicado: (2019)

Streamlined structure determination by cryo-electron tomography and subtomogram averaging using TomoBEAR
por: Balyschew, Nikita, et al.
Publicado: (2023)

Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model
por: Morris, Aaron, et al.
Publicado: (2021)

Deep Learning-Driven Library Design for the De Novo Discovery of Bioactive Thiopeptides
por: Chang, Jun Shi, et al.
Publicado: (2023)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
por: Gao, Menghan, et al.
Publicado: (2023)

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021)

AI-driven drug discovery: A boon against COVID-19?
por: Chandra Kaushik, Aman, et al.
Publicado: (2020)

Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332
por: Li, Jian, et al.
Publicado: (2022)

Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814
por: Li, Jian, et al.
Publicado: (2022)

Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)

Molecular representations in AI-driven drug discovery: a review and practical guide
por: David, Laurianne, et al.
Publicado: (2020)

AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate()
por: Delijewski, Marcin, et al.
Publicado: (2021)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease
por: Deodato, Davide, et al.
Publicado: (2022)

Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings
por: Dong, Jie, et al.
Publicado: (2022)

Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection
por: Ge, Rui, et al.
Publicado: (2022)

Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach
por: Augustin, Teresa L., et al.
Publicado: (2020)

Computational screening for potential drug candidates against the SARS-CoV-2 main protease
por: Silva Andrade, Bruno, et al.
Publicado: (2020)

Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery
por: Zakharova, Maria Yu., et al.
Publicado: (2021)

In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor
por: Wen, Lei, et al.
Publicado: (2021)

Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease
por: Elkaeed, Eslam B., et al.
Publicado: (2022)

The AI for Scientific Discovery Network(+)
por: Kanza, Samantha, et al.
Publicado: (2021)

AI-driven robotic chemist for autonomous synthesis of organic molecules
por: Ha, Taesin, et al.
Publicado: (2023)

De novo assembly of the pepper transcriptome (Capsicum annuum): a benchmark for in silico discovery of SNPs, SSRs and candidate genes
por: Ashrafi, Hamid, et al.
Publicado: (2012)

De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning
por: Santana, Marcos V. S., et al.
Publicado: (2021)

Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates
por: Yoshino, Ryunosuke, et al.
Publicado: (2020)

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
por: Dai, Wenhao, et al.
Publicado: (2020)

Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules
por: Gentile, Francesco, et al.
Publicado: (2021)

The Golgi apparatus and main discoveries in the field of intracellular transport
por: Mironov, Alexander A., et al.
Publicado: (2008)

Thermodynamic and structural insights into the repurposing of drugs that bind to SARS-CoV-2 main protease
por: Wan, Shunzhou, et al.
Publicado: (2021)

From intuition to AI: evolution of small molecule representations in drug discovery
por: McGibbon, Miles, et al.
Publicado: (2023)

Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
por: Cheng, Bijun, et al.
Publicado: (2020)

Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease
por: Kandeel, Mahmoud, et al.
Publicado: (2022)

Discovery of 4′-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor
por: Wu, Qianqian, et al.
Publicado: (2022)

In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
por: Muhtar, Eldar, et al.
Publicado: (2021)

Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases
por: Kühl, Nikos, et al.
Publicado: (2022)

Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method
por: Zhang, Huijun, et al.
Publicado: (2023)

Chromatin-driven de novo discovery of DNA binding motifs in the human malaria parasite
por: Harris, Elena Y, et al.
Publicado: (2011)

Multistep rational molecular design and combined docking for discovery of novel classes of inhibitors of SARS-CoV-2 main protease 3CLpro
por: Tumskiy, Roman S., et al.
Publicado: (2021)

SynAI: an AI-driven cancer drugs synergism prediction platform
por: Yan, Kuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rft8a89eq65qm23e6cd1sg2ds6